We noted that the GREM2 gene was upstream of the TGF-β pathway, and its expression in the drug-resistant PC samples was significantly decreased, which indicated that it likely affected the resistance of PC to taxane chemotherapy by regulating TGF-β. This evidence concerns the gene GREM2 and pachyonychia congenita.